Most cardiovascular studies have implicated the central transcription factor nuclear factor kappa B (NF-κB) as contributing to the detrimental effects of cardiac injury. This ostensibly negative view of NF-κB competes with its important role in the normal host inflammatory and immune response. Pressure-overload, left ventricular hypertrophy (LVH), and heart failure represent a spectrum of disease that has both adaptive and maladaptive components. As opposed to its known effects related to myocardial ischemia-reperfusion, we hypothesized that NF-κB is necessary for the compensatory phase of cardiac remodeling
Objective: We have previously demonstrated that nuclear factor kappa B (NFκB) activation is needed f...
Objective: We have previously demonstrated that nuclear factor kappa B (NFκB) activation is needed f...
Objective: We have previously demonstrated that nuclear factor kappa B (NFκB) activation is needed f...
Most cardiovascular studies have implicated the central transcription factor nuclear factor kappa B ...
Cardiac hypertrophy is a maladaptive response to an injury, characterized by an increase in cell siz...
Cardiac hypertrophy is a maladaptive response to an injury, characterized by an increase in cell siz...
Background - In vitro experiments have proposed a role of nuclear factor-κB (NF-κB), a transcription...
AbstractNuclear factor kappa-B (NFκB), a redox-sensitive transcription factor regulating a battery o...
<div><p>The transcription factor NF-κB has been associated with a range of pathological conditions o...
Abstract—Cardiomyocyte death plays an important role in the pathogenesis of heart failure. The nucle...
The transcription factor NF-κB has been associated with a range of pathological conditions of the he...
No-reflow phenomenon is a risk factor which severely compromises the benefits of coronary revascular...
BACKGROUND:Inflammation is associated with cardiac remodeling and heart failure, but how it is initi...
BACKGROUND:Inflammation is associated with cardiac remodeling and heart failure, but how it is initi...
BACKGROUND: Myocardial hypertrophy is an independent risk factor for heart failure (HF), yet the mec...
Objective: We have previously demonstrated that nuclear factor kappa B (NFκB) activation is needed f...
Objective: We have previously demonstrated that nuclear factor kappa B (NFκB) activation is needed f...
Objective: We have previously demonstrated that nuclear factor kappa B (NFκB) activation is needed f...
Most cardiovascular studies have implicated the central transcription factor nuclear factor kappa B ...
Cardiac hypertrophy is a maladaptive response to an injury, characterized by an increase in cell siz...
Cardiac hypertrophy is a maladaptive response to an injury, characterized by an increase in cell siz...
Background - In vitro experiments have proposed a role of nuclear factor-κB (NF-κB), a transcription...
AbstractNuclear factor kappa-B (NFκB), a redox-sensitive transcription factor regulating a battery o...
<div><p>The transcription factor NF-κB has been associated with a range of pathological conditions o...
Abstract—Cardiomyocyte death plays an important role in the pathogenesis of heart failure. The nucle...
The transcription factor NF-κB has been associated with a range of pathological conditions of the he...
No-reflow phenomenon is a risk factor which severely compromises the benefits of coronary revascular...
BACKGROUND:Inflammation is associated with cardiac remodeling and heart failure, but how it is initi...
BACKGROUND:Inflammation is associated with cardiac remodeling and heart failure, but how it is initi...
BACKGROUND: Myocardial hypertrophy is an independent risk factor for heart failure (HF), yet the mec...
Objective: We have previously demonstrated that nuclear factor kappa B (NFκB) activation is needed f...
Objective: We have previously demonstrated that nuclear factor kappa B (NFκB) activation is needed f...
Objective: We have previously demonstrated that nuclear factor kappa B (NFκB) activation is needed f...